Mega Genomics Limited (HKG:6667)
Hong Kong
· Delayed Price · Currency is HKD 7.20
-0.05 (-0.69%)
Mar 31, 2025, 3:45 PM HKT
Mega Genomics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 159.71 | 151.3 | 145.73 | 237.19 | 203.22 | 123.7 |
| Revenue Growth (YoY) | 8.66% | 3.82% | -38.56% | 16.71% | 64.28% | - |
| Cost of Revenue | 67.1 | 63 | 64 | 70.51 | 56.98 | 45.22 |
| Gross Profit | 92.62 | 88.3 | 81.72 | 166.68 | 146.24 | 78.48 |
| Selling, General & Admin | 65.65 | 75.21 | 77.79 | 45.95 | 35.4 | 20.22 |
| Other Operating Expenses | 1.21 | 0.78 | 2.48 | 5.87 | 3.8 | 8.45 |
| Operating Expenses | 60.61 | 62.01 | 106.13 | 57.98 | 38.47 | 35.12 |
| Operating Income | 32.01 | 26.28 | -24.4 | 108.69 | 107.77 | 43.35 |
| Interest Expense | -1.79 | -1.12 | -0.72 | -6.91 | -16.55 | -19.59 |
| Interest & Investment Income | 5.72 | 6.07 | 4.01 | 2.98 | 0.34 | 0.04 |
| Currency Exchange Gain (Loss) | 0.1 | 1.44 | 11.75 | - | - | - |
| Other Non Operating Income (Expenses) | 0.89 | 3.51 | -12.06 | -8.94 | 3.24 | 14.49 |
| EBT Excluding Unusual Items | 36.92 | 36.18 | -21.42 | 95.82 | 94.8 | 38.29 |
| Gain (Loss) on Sale of Investments | - | - | - | 0.06 | 0.1 | - |
| Pretax Income | 36.92 | 36.18 | -21.42 | 95.88 | 94.9 | 38.29 |
| Income Tax Expense | 5.03 | 6.14 | -3.8 | 16.87 | 15.81 | 8.6 |
| Net Income | 31.89 | 30.04 | -17.62 | 79.02 | 79.1 | 29.69 |
| Net Income to Common | 31.89 | 30.04 | -17.62 | 79.02 | 79.1 | 29.69 |
| Net Income Growth | - | - | - | -0.10% | 166.40% | - |
| Shares Outstanding (Basic) | 206 | 212 | 206 | 127 | - | - |
| Shares Outstanding (Diluted) | 206 | 212 | 206 | 127 | - | - |
| Shares Change (YoY) | -4.83% | 2.65% | 62.09% | - | - | - |
| EPS (Basic) | 0.15 | 0.14 | -0.09 | 0.62 | - | - |
| EPS (Diluted) | 0.15 | 0.14 | -0.09 | 0.62 | - | - |
| Free Cash Flow | 87.53 | 127.83 | -11.92 | 26.47 | 101.79 | 36.69 |
| Free Cash Flow Per Share | 0.42 | 0.60 | -0.06 | 0.21 | - | - |
| Gross Margin | 57.99% | 58.36% | 56.08% | 70.27% | 71.96% | 63.44% |
| Operating Margin | 20.04% | 17.37% | -16.75% | 45.83% | 53.03% | 35.05% |
| Profit Margin | 19.97% | 19.85% | -12.09% | 33.31% | 38.92% | 24.00% |
| Free Cash Flow Margin | 54.81% | 84.49% | -8.18% | 11.16% | 50.09% | 29.66% |
| EBITDA | 40 | 34.54 | -16.08 | 117.05 | 116.31 | 51.93 |
| EBITDA Margin | 25.05% | 22.83% | -11.03% | 49.35% | 57.23% | 41.98% |
| D&A For EBITDA | 7.99 | 8.26 | 8.33 | 8.36 | 8.53 | 8.57 |
| EBIT | 32.01 | 26.28 | -24.4 | 108.69 | 107.77 | 43.35 |
| EBIT Margin | 20.04% | 17.37% | -16.75% | 45.83% | 53.03% | 35.05% |
| Effective Tax Rate | 13.62% | 16.97% | - | 17.59% | 16.66% | 22.46% |
| Advertising Expenses | - | - | - | - | 14.1 | 0.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.